Insider Transactions in Q1 2023 at Ngm Biopharmaceuticals Inc (NGM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
Mangini Siobhan Nolan President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
76,000
+50.0%
|
-
|
|
Mar 02
2023
|
Jin Long Chen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,000
+6.17%
|
-
|
|
Mar 02
2023
|
Hsiao D Lieu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+48.8%
|
-
|
|
Mar 02
2023
|
David J Woodhouse Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
127,200
+46.76%
|
-
|
|
Mar 02
2023
|
Valerie L Pierce |
BUY
Grant, award, or other acquisition
|
Direct |
49,000
+46.82%
|
-
|
|
Jan 31
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
530,190
+16.01%
|
$2,650,950
$5.0 P/Share
|
|
Jan 31
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
176,730
+16.01%
|
$883,650
$5.0 P/Share
|
|
Jan 30
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
22,626
+0.99%
|
$113,130
$5.0 P/Share
|
|
Jan 30
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
7,542
+0.99%
|
$37,710
$5.0 P/Share
|
|
Jan 23
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
29,700
+1.32%
|
$148,500
$5.0 P/Share
|
|
Jan 23
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
9,900
+1.32%
|
$49,500
$5.0 P/Share
|
|
Jan 20
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+0.07%
|
$7,500
$5.0 P/Share
|
|
Jan 20
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
500
+0.07%
|
$2,500
$5.0 P/Share
|
|
Jan 19
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
112,917
+4.89%
|
$564,585
$5.0 P/Share
|
|
Jan 19
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
37,639
+4.89%
|
$188,195
$5.0 P/Share
|
|
Jan 17
2023
|
Jin Long Chen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
85,082
-8.56%
|
$425,410
$5.15 P/Share
|
|
Jan 17
2023
|
Jin Long Chen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
85,082
+7.88%
|
$85,082
$1.44 P/Share
|
|
Jan 12
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
16,134
+0.77%
|
$64,536
$4.95 P/Share
|
|
Jan 12
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
5,378
+0.77%
|
$21,512
$4.95 P/Share
|
|
Jan 11
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
627,000
+23.26%
|
$2,508,000
$4.76 P/Share
|
|
Jan 11
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
209,000
+23.26%
|
$836,000
$4.76 P/Share
|
|
Jan 10
2023
|
Column Group L P Director |
BUY
Open market or private purchase
|
Indirect |
300,210
+17.24%
|
$1,200,840
$4.84 P/Share
|
|
Jan 10
2023
|
David V Goeddel Director |
BUY
Open market or private purchase
|
Indirect |
100,070
+17.24%
|
$400,280
$4.84 P/Share
|